What is it about?
It's research involving two drugs such as DULOXETINE and GABAPENTIN. We compare the two drugs for the pain in diabetic neuropathy patient's. It is open label, randomized controlled trial. We compare the efficacy by evaluating pain scores. We found that two drugs are decrease the pain substantially with minimal side effects.
Photo by Sharon McCutcheon on Unsplash
Why is it important?
As this is RCT, DULOXETINE and GABAPENTIN never compared head to head for painful diabetic neuropathy patients. So we found that both the drugs show comparable efficacy with minimal side effect profile.
Read the Original
This page is a summary of: A randomized control trial of duloxetine and gabapentin in painful diabetic neuropathy, Journal of Diabetes, January 2021, Wiley,
You can read the full text:
The following have contributed to this page